Romark patents expiration
1. Alinia patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6020353 | ROMARK | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide |
Sep, 2014
(9 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5578621 | ROMARK | Benzamide derivatives |
Sep, 2014
(9 years ago) | |
| US6020353 | ROMARK | 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide |
Sep, 2014
(9 years ago) | |
| US5968961 | ROMARK | Pharmaceutical compositions of tizoxanide and nitazoxanide |
May, 2017
(6 years ago) | |
| US6117894 | ROMARK | Acid stabilized pharmaceutical compositions of tizoxanide and nitazoxanide |
May, 2017
(6 years ago) | |
| US5965590 | ROMARK | Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide |
Jul, 2017
(6 years ago) | |
Drugs and Companies using NITAZOXANIDE ingredient
Market Authorisation Date: 21 July, 2004
Treatment: Method of treating parasitic infections; Method of treating infection by cryptosporidium parvum in an immunocompromised mammal
Dosage: TABLET;ORAL; FOR SUSPENSION;ORAL
More Information on Dosage
ALINIA family patents
